Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11-009, Initial Review, 20355 [2011-8658]

Download as PDF Federal Register / Vol. 76, No. 70 / Tuesday, April 12, 2011 / Notices Influenza Pandemic or Other Public Health Emergency. The National Biosurveillance Advisory Subcommittee will submit their report entitled, ‘‘Improving the Nation’s Ability to Detect and Respond to 21st Century Urgent Health Threats: Second Report of the National Biosurveillance Advisory Subcommittee,’’ for approval. The State, Tribal, Local and Territorial (STLT) Workgroup will provide Directional Recommendations for Enhancing CDC Support to the STLT Community. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Carmen Villar, MSW, Designated Federal Officer, ACD, CDC, 1600 Clifton Road, NE., Mailstop D–14, Atlanta, Georgia 30333, Telephone: (404) 639–7000. E-mail: GHickman@cdc.gov. The deadline for notification of attendance is April 25, 2011. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Research in Thailand by the Ministry of Public Health (MOPH) (U01),’’ FOA GH11– 002, initial review. Contact Person for More Information: Susan B. Stanton, D.D.S., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, Georgia 30333, Telephone: (404) 639–4640. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 5, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention [FR Doc. 2011–8657 Filed 4–11–11; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial Review srobinson on DSKHWCL6B1PROD with NOTICES The meeting announced below concerns ‘‘Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH) (U01),’’ FOA GH11–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1 p.m.–4 p.m., May 26, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health 18:00 Apr 11, 2011 Jkt 223001 [FR Doc. 2011–8659 Filed 4–11–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11–009, Initial Review The meeting announced below concerns ‘‘Public Health Research for the Prevention of Complications of Bleeding,’’ FOA DD11–009, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 Dated: April 5, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Time and Date: 10 a.m.–5 p.m., May 19, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Public Health Research for the Prevention of Complications of Bleeding,’’ FOA DD11–009, initial review. Contact Person for More Information: Michael Dalmat, Dr.PH., Scientific Review Officer, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, Georgia 30341, Telephone: (770) 488–6423, E-mail: MED1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 20355 pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 5, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–8658 Filed 4–11–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial Review The meeting announced below concerns Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet); Feasibility of Expansion to Other Muscular Dystrophies (FOA) DD11–006, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–5 p.m., May 10, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet); Feasibility of Expansion to Other Muscular Dystrophies (FOA) DD11– 006, initial review.’’ Contact Person for More Information: Brenda Colley Gilbert, Ph.D., M.P.H., Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Developmental Disabilities, CDC, 1600 Clifton Road, NE., Mailstop K92, Atlanta, Georgia 30333, Telephone: (770) 488–6295. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 76, Number 70 (Tuesday, April 12, 2011)]
[Notices]
[Page 20355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8658]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Funding Opportunity Announcement (FOA) DD11-009, 
Initial Review

    The meeting announced below concerns ``Public Health Research for 
the Prevention of Complications of Bleeding,'' FOA DD11-009, initial 
review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 10 a.m.-5 p.m., May 19, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Public Health Research for the Prevention of 
Complications of Bleeding,'' FOA DD11-009, initial review.
    Contact Person for More Information: Michael Dalmat, Dr.PH., 
Scientific Review Officer, Extramural Research Program Office, 
National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, Georgia 
30341, Telephone: (770) 488-6423, E-mail: MED1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: April 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-8658 Filed 4-11-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.